Hormone-dependent tumors rise in size considerably inside the presence of the corresponding hormone inside the blood. This pathophysiology gives a potential avenue for managing these cancers. Given that about 70 % of all breast cancers are hormone receptor-good, these endocrine brokers are of utmost